[Risk stratification of progressive multifocal leukoencephalopathy under natalizumab: recommendations for JC virus serology]

Nervenarzt. 2011 Oct;82(10):1314-9. doi: 10.1007/s00115-011-3319-2.
[Article in German]
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antibodies, Viral / blood*
  • Drug Therapy, Combination
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • JC Virus / immunology*
  • Leukoencephalopathy, Progressive Multifocal / chemically induced*
  • Long-Term Care
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Natalizumab
  • Risk Factors

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Viral
  • Immunosuppressive Agents
  • Natalizumab